|
REGISTER OF TRADE MARKS INTERNATIONAL TRADE MARK PROTECTED IN THE STATE | |||
| Status | Protected | Registration No. | 1045463 |
|---|---|---|---|
| Holder |
HASCO TM spólka z ograniczona odpowiedzialnoscia spólka komandytowa ul. Zmigrodzka 242E PL-51-131 Wroclaw POLAND |
||
| Description of Mark | Glandex | ||
| Representation of Mark |
|
||
| Goods & Services |
Class: 5 Pharmaceutical products, chemical preparations for medicinal purposes, chemical preparations for pharmaceutical purposes, hormones for medical purposes, medicines for human purposes, pills for pharmaceutical purposes, pills for pharmaceutical use, anticancer preparations, antineoplastic agents, medicines containing inhibitors, drugs reducing estrogen, drugs used to treat hormone-dependent cancers, medicines containing of aromatase inhibitors, drugs regulating levels of hormones, drugs used for postmenopausal women. |
||
| Designation Date | 07/05/2010 | ||
| Priority Date | 09/11/2009 | ||
| Registration Renewed | 08/05/2020 | ||
| Date of Notification from International Bureau | 19/08/2010 | ||
| Date of Publication of Protection | 13/04/2011 | ||
| Expiry Date | 07/05/2030 | ||
| Address for Service WIPO |
HASCO TM spólka z ograniczona odpowiedzialnoscia spólka komandytowa ul. Zmigrodzka 242E PL-51-131 Wroclaw POLAND |
||
| Name and Address of WIPO Representative |
Magdalena Krekora ul. Górna 95 PL-32-091 Michalowice POLAND |
||
| Name and Address for Service within the EU |
Magdalena Krekora Ul. Górna 95 32-091 Michalowice Krakow POLAND |
||
| Colour Claimed | White, blue, violet, dark violet, light violet and grey. | ||
| Notings | |||
| 13/05/2016 | Assignment of International Trade Mark No.1045463 from Przedsiebiorstwo Produkcji Farmaceutycznej Hasco-Lek S.A., ul. Zmigrodzka 242E, PL-51-131 Wroclaw, Poland to HASCO TM spólka z ograniczona odpowiedzialnoscia spólka komandytowa, ul. Zmigrodzka 242E, PL-51-131 Wroclaw, Poland recorded in the International Register on 23/02/2016. | ||
| 05/05/2022 | Registration partially revoked in respect of "capsules for pharmaceutical purposes" and "analgesics" in Class 5 with effect from 30 January 2019 following proceedings pursuant to Section 51 of the 1996 Act. | ||
